Jacob Vanlandingham - May 19, 2022 Form 4 Insider Report for Odyssey Health, Inc. (ODYY)

Role
VP of Drug Development
Signature
/s/ Christine M. Farrell, Attorney-in-Fact for Jacob Vanlandingham
Stock symbol
ODYY
Transactions as of
May 19, 2022
Transactions value $
$30,000
Form type
4
Date filed
6/8/2022, 05:18 PM
Next filing
Jun 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ODYY Stock Option (Right to Buy) Award $30K +100K +10% $0.30 1.1M May 19, 2022 Common Stock 100K $0.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting Schedule: 50% vest on first dosed subject of Phase 2 Trial; 50% on last dosed subject of Phase 2 Trial.